Clinical Epidemiology and Management of Hidradenitis Suppurativa. Issue 4 (April 2021)

• Record Type: Journal Article
• Authors: Sayed, Christopher J.; Hsiao, Jennifer L.; Okun, Martin M.
• Is Part Of: Obstetrics and gynecology. Volume 137:Issue 4(2021)
• Publication Date: 2021-04
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; 618
• DOI: 10.1097/AOG.0000000000004321
• Languages: English
• ISSNs: 0029-7844

Abstract

Abstract : Hidradenitis suppurativa is a chronic immune-mediated inflammatory skin disease with a prevalence of 0.1–1%, characterized by nodules and abscesses in the axillae, groin, and inframammary areas, sometimes developing into tunnels (or fistulas) and scars. Because hidradenitis suppurativa is more common in women and in those aged 18–40 years, obstetrician–gynecologists (ob-gyns) have the opportunity to diagnose, educate, initiate treatment, and coordinate care with ancillary health care professionals. The recently published North American treatment guidelines, along with management information for patients with hidradenitis suppurativa who are pregnant or breastfeeding, are summarized. By diagnosing and optimizing hidradenitis suppurativa treatment early in the disease course, ob-gyns can reduce morbidity, with the potential to favorably alter disease trajectory. Abstract : Understanding hidradenitis suppurativa clinical epidemiology and management facilitates early diagnosis and treatment, thereby reducing morbidity with the potential to favorably alter disease trajectory.